Patents by Inventor Jacques Pappo

Jacques Pappo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bead-containing dry powder inhaler
    Patent number: 8651104
    Abstract: A dry powder inhaler includes a chamber holding a bead-like actuator to which a powdered medicament is adhered. Air is drawn into the chamber through an inlet flow channel and exits through an outlet flow channel. The bead-like actuator oscillates in response to the air flow, dislodging powdered medicament to be entrained in the air flow and delivered to the patient.
    Type: Grant
    Filed: May 11, 2012
    Date of Patent: February 18, 2014
    Assignee: Respira Therapeutics, Inc.
    Inventors: Martin J. Donovan, Jacques Pappo, Hugh Smyth
  • Dry powder inhaler
    Patent number: 8561609
    Abstract: A dry powder inhaler includes a chamber holding an actuator to which a powdered medicament is adhered. Air is drawn into the chamber through an inlet flow channel and exits through an outlet flow channel. The actuator oscillates in response to the air flow, dislodging powdered medicament to be entrained in the air flow and delivered to the patient. A retaining member prevents the actuator from exiting the chamber. Thus, the medicament may be delivered to the patient without the use of carrier particles.
    Type: Grant
    Filed: December 7, 2011
    Date of Patent: October 22, 2013
    Assignee: Respira Therapeutics, Inc.
    Inventors: Martin Donovan, Jacques Pappo, Hugh Smyth
  • BEAD-CONTAINING DRY POWDER INHALER
    Publication number: 20120291780
    Abstract: A dry powder inhaler includes a chamber holding a bead-like actuator to which a powdered medicament is adhered. Air is drawn into the chamber through an inlet flow channel and exits through an outlet flow channel. The bead-like actuator oscillates in response to the air flow, dislodging powdered medicament to be entrained in the air flow and delivered to the patient.
    Type: Application
    Filed: May 11, 2012
    Publication date: November 22, 2012
    Applicant: Respira Therapeutics, Inc.
    Inventors: Martin J. Donovan, Jacques Pappo, Hugh Smyth
  • DRY POWDER INHALER
    Publication number: 20120145150
    Abstract: A dry powder inhaler includes a chamber holding an actuator to which a powdered medicament is adhered. Air is drawn into the chamber through an inlet flow channel and exits through an outlet flow channel. The actuator oscillates in response to the air flow, dislodging powdered medicament to be entrained in the air flow and delivered to the patient. A retaining member prevents the actuator from exiting the chamber. Thus, the medicament may be delivered to the patient without the use of carrier particles.
    Type: Application
    Filed: December 7, 2011
    Publication date: June 14, 2012
    Applicant: Respira Therapeutics, Inc.
    Inventors: Martin J. Donovan, Jacques Pappo, Hugh Smyth
  • Multimeric, recombinant urease vaccine
    Patent number: 5837240
    Abstract: Methods and compositions are provided for prophylactic and antibacterial therapy for Helicobacter, particularly for Helicobacter pylori, infection of humans. The immunogenic composition of the invention is composed of a plurality of multimeric complexes, each complex being composed of recombinant, enzymatically inactive Helicobacter pylori urease. Each multimeric complex is composed of six Urease A subunits and six Urease B subunits. Alternatively, the composition is composed of a mixture of multimeric complexes, wherein each multimeric complex in the mixture is composed of six Urease A subunits and six Urease B subunits or four Urease A subunits and four Urease B subunits.
    Type: Grant
    Filed: August 26, 1997
    Date of Patent: November 17, 1998
    Assignee: OraVax-Merieux Co.
    Inventors: Cynthia K. Lee, Thomas P. Monath, Samuel K. Ackerman, William D. Thomas, Gopalan Soman, Harold Kleanthous, Richard A. Weltzin, Jacques Pappo, Thomas Ermak, Farshad Guirakhoo, Hitesh Bhagat, Ilene Sussman
  • Oral immunization with multiple particulate antigen delivery system
    Patent number: 5690938
    Abstract: Method of inducing a mucosal and or/systemic immune response in a host, comprising the step of administering to the host an effective amount of a Bluetongue antigen in the form of virus like and/or virus core like particles. Vaccines are also provided.
    Type: Grant
    Filed: October 5, 1993
    Date of Patent: November 25, 1997
    Assignees: Oravax, Inc., Natural Environment Research Council
    Inventors: Thomas H. Ermak, Jacques Pappo, Farshad Guirakhoo, Richard D. Nichols, Jr., Thomas P. Monath, Polly Roy